Global Continuous Renal Replacement Therapy Market To Reach Worth US$ 1,653.8 Mn By 2025

According to the latest report published by Credence Research, Inc. “Continuous Renal Replacement Therapy Market – Growth, Future Prospects and Competitive Analysis, 2017-2025,” the global continuous renal replacement therapy market was valued at US$ 856.2 Mn in 2016, and is expected to reach US$ 1,653.8 Mn by 2025, expanding at a CAGR of 7.47% from 2017 to 2025.

Browse the full report Continuous Renal Replacement Therapy Market – Growth, Future Prospects and Competitive Analysis, 2017–2025 at

Market Insights                                   

Acute dialysis-dependent renal failure is a common issue in ICU patients. Despite significant improvement in patient care in ICUs, the mortality arising from acute renal failure in ICU remains at over 50%. Over the past 20 years, significant improvement has taken place in the field of hemodialysis and the approach to the treatment of acute renal failure has underwent transformation. Use of novel, user friendly and safer devices has permitted medical practitioner to achieve well-tolerated, efficient and safe renal replacement therapy.

Patient with acute renal failure often require renal replacement therapy when there is a significant decline in glomerular filtration rate or at the risk of developing solute toxicity. Continuous renal replacement therapy is applied to acute renal failure patients in the ICU. CRRT refers to a collection of blood purification techniques with inherent differences with respect to mechanism of solute transport, presence of lack of dialysate solution, type of membrane and vascular access.

Based on product types, the global continuous renal replacement therapy market is categorized into systems and consumables (filters, tubing sets and disposables). Between these, the consumables segment occupies the larger revenue share and will continue its dominance through the forecast period. Greater consumption volume of filters, fluids and other such disposables mainly contribute to the dominance of this segment. On the other hand, systems segment will witness steady growth during the forecast period due to increasing prevalence of acute renal failure in hospitalized patients and technological development in CRRT systems with respect to greater filtration volume and higher permeability.

Among the various modalities of CRRT, continuous veno-venous hemofiltration (CVVH) dominated the market in 2016 due to rise in incidence of fluid overload in hospitalized patients. Fluid overload is often a causative symptom in patients with congestive heart failure. Additionally continuous veno-venous hemodiafiltration (CVVHDF) segment is expected to witness the fastest growth rate during the forecast period. This modality performs complete solute replacement and follows the principles of both hemodialysis and hemofiltration with the use of hemodiafilters.

Geographically, North America is the largest regional market for continuous renal replacement therapy. Growing demand for CRRT in hospitals and multispecialty centers and rapid adoption of advanced solutions majorly drive the North America market. The demand for CRRT devices is high in the U.S. due to growing prevalence of acute renal failure in the country due to growing hospital admissions attributed to chronic disease complications. Additionally, it is expected that Asia Pacific on the ground of its large population base and rapid development of healthcare infrastructure and swift addition to the number of hospitals being established will be the fastest growing regional market during the forecast period.